Skip to main content
Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
8.60
+1.75 (25.55%)
Mar 9, 2026, 3:32 PM EDT - Market open

Cartesian Therapeutics Revenue

In the year 2025, Cartesian Therapeutics had annual revenue of $2.80M, down -92.81%. Cartesian Therapeutics had revenue of $947.00K in the quarter ending December 31, 2025, a decrease of -224.77%.

Revenue (ttm)
$2.80M
Revenue Growth
-92.81%
P/S Ratio
79.12
Revenue / Employee
$42,379
Employees
66
Market Cap
223.63M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20252.80M-36.12M-92.81%
Dec 31, 202438.91M12.91M49.64%
Dec 31, 202326.00M-84.77M-76.53%
Dec 31, 2022110.78M25.70M30.21%
Dec 31, 202185.08M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Keros Therapeutics 244.06M
Protalix BioTherapeutics 61.84M
Editas Medicine 40.52M
Voyager Therapeutics 31.32M
Sol-Gel Technologies 18.97M
MediWound 16.96M
Revenue Rankings

RNAC News

More News